Clinical Trial Update: Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating prophylactic or preemptive entecavir to prevent hepatitis B reactivation in gastric cancer patients who are inactive hepatitis B carr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Stomach Neoplasms | Phase 2 | Status: UNKNOWN